Piramal Pharma Ltd has published its third annual Sustainability Report for FY 2023-24, highlighting commitments to reducing emissions and improving energy efficiency, with a goal of 42% reduction in Scope 1 and 2 GHG emissions and 25% in Scope 3 emissions by FY 2030, along with a 29% increase in renewable energy consumption and significant waste recycling efforts.